home / stock / bold / bold news


BOLD News and Press, Audentes Therapeutics Inc. From 12/18/19

Stock Information

Company Name: Audentes Therapeutics Inc.
Stock Symbol: BOLD
Market: NASDAQ
Website: boundlessbio.com

Menu

BOLD BOLD Quote BOLD Short BOLD News BOLD Articles BOLD Message Board
Get BOLD Alerts

News, Short Squeeze, Breakout and More Instantly...

BOLD - READ NOW: Monteverde & Associates PC Reminds Investors of its Ongoing Investigation Regarding the Transaction

NEW YORK, NY / ACCESSWIRE / December 18, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Tiffany & Co. (NYSE: TIF ) relating t...

BOLD - Merger Arbitrage Analysis And Spread Performance - December 15, 2019

This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position ...

BOLD - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - BOLD, AKS, INST, THOR

NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Audentes Therapeutics, Inc. (NASDAQ: BOLD) The investigation concerns whether Audentes and its board of directors violated the federal secu...

BOLD - URGENT NEWS: Monteverde & Associates PC Reminds Investors of its Ongoing Investigation Regarding the Merger

NEW YORK, NY / ACCESSWIRE / December 13, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Audentes Therapeutics, Inc ( BOLD ) relat...

BOLD - AVROBIO: Promise In Fabry Disease

Capital Structure Price per share: ~$21 | Market capitalization: ~$650M Cash and cash equivalents: $206M | Debt: NA Cash burn: ~$20M/quarter | Cash runway: into 2021 Commercial assets: 0 | Phase 3: 0 | Phase 2: 1 | Phase 1: 2 Introduction AVROBIO ( AVRO ) is a phase 2 biotechn...

BOLD - STOCKHOLDER ALERT: Monteverde & Associates PC Continues its Legal Inquiry for the Recent Acquisition

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Instructure, Inc ( INST ) related to its sale...

BOLD - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - INST, AKS, BOLD, SORL

NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Instructure, Inc. (NYSE: INST) The investigation concerns whether Instructure and its board of directors violated the federal securities la...

BOLD - Merger Arbitrage Analysis And Spread Performance - December 8, 2019

This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position or...

BOLD - Merger Arbitrage Mondays - Thoma Bravo's Acquisition Of Instructure Includes A Go-Shop Provision

Merger activity increased with five new deals announced and five deals closing. Deal Statistics New Deals The acquisition of Audentes Therapeutics (BOLD) by Astellas Pharma (ALPMF) for $2.65 billion or $60.00 per share in cash. The acquisition of AK Steel Holding Corporation...

BOLD - Sundar Pichai The New Alphabet CEO, Congrats Here's Your 'To Dos', Also Salesforce, Workday, And Coupa Earnings

Congratulations to Sundar Pichai, this is what you need to do with Alphabet Can you please just dump the Alphabet (GOOG) (GOOGL) name and go back to Google? No one calls you Alphabet, so it just confuses everyone. Also "Other bets" are like 0.07% of revenue, so do you really need a holdi...

Previous 10 Next 10